Daniel O. Rico-Suarez
Guadalajara, JAL 44340, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Bidirectional Interactions Between Cervicovaginal Microbiota and Human Papillomavirus Drive Persistence and Disease Progression.
Journal: International journal of molecular sciences
Published: April 16, 2026
Biomarkers and Endothelial Damage in Obesity: An Insight into the Pharmacological Modulation.
Journal: International journal of molecular sciences
Published: March 11, 2026
The Gut Microbiota in Parkinson's Disease: Mechanistic Insights into Microbial-Host Interactions.
Journal: Microorganisms
Published: February 10, 2026
Enteric Infections, Dysbiosis, and Metabolic Dysfunction: The Role of Diarrheagenic Pathogens in Insulin Resistance.
Journal: International journal of molecular sciences
Published: December 12, 2025
Epidemiological Assessment of Benzodiazepine Dependence via Pharmacist-Led EMR Review in Pain and Palliative Care Institution.
Journal: Pharmacy (Basel, Switzerland)
Published: November 19, 2025
Opposing profiles of Netrin-1 and adiponectin in metabolic inflammation and insulin resistance.
Journal: Frontiers in pharmacology
Published: May 21, 2025
Empagliflozin Leads to Faster Improvement in Arterial Stiffness Compared to Dapagliflozin: A Double-Blind Clinical.
Journal: Life (Basel, Switzerland)
Published: March 19, 2025
The Role of Resistin in Macrovascular and Microvascular Complications of Type 2 Diabetes.
Journal: Life (Basel, Switzerland)
Published: February 06, 2025
Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.
Journal: International journal of molecular sciences
Published: January 13, 2025
Correction: Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. J. Cardiovasc. Dev. Dis. 2024, 11, 182.
Journal: Journal of cardiovascular development and disease
Published: August 20, 2024
Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial.
Journal: Journal of cardiovascular development and disease
Published: April 29, 2024
Decoding the Gut Microbiota-Gestational Diabetes Link: Insights from the Last Seven Years.
Journal: Microorganisms
Published: March 27, 2024
Last Updated: 09/26/2026